Daiwa Securities Group
GILD icon

Daiwa Securities Group’s Gilead Sciences GILD Stock Holding History

Daiwa Securities Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-60,923
Closed -$7.13M – 965
2015
Q2 		$7.13M Buy
+60,923
New +$6.66M 0.05% 147

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Daiwa Securities Group's GILD Position: Q2 2026 in Review

Daiwa Securities Group increased its Gilead Sciences (GILD) stake by 7.9% in Q2 2026, buying an estimated $3.47M and bringing the position to 361,938 shares worth $45.7M. The position accounts for 0.09% of the portfolio, ranked #127.

Daiwa Securities Group first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $46.8M in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Daiwa Securities Group held 361,938 shares of Gilead Sciences worth $45.7M as of Q2 2026.
  • Daiwa Securities Group bought 26,366 Gilead Sciences shares in Q2 2026, an estimated $3.47M.
  • Gilead Sciences made up 0.09% of Daiwa Securities Group's portfolio in Q2 2026, its #127 holding.
  • Daiwa Securities Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Daiwa Securities Group's Gilead Sciences position peaked at $46.8M in Q1 2026.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.